Vera Therapeutics Acquires Global Rights to Novel, Next Generation Dual BAFF/APRIL Inhibitor by Seini Moimoi | Jan 13, 2025 | Portfolio News
Alentis Announces Positive Topline Results from Two Studies of Lixudebart (ALE.F02) in Patients with ANCA-RPGN and Advanced Liver Fibrosis by Seini Moimoi | Jan 9, 2025 | Portfolio News
Quanta Announces IND Clearance by U.S. FDA for QTX3544, an Oral G12V-Preferring Multi-KRAS Inhibitor, and Other Pipeline Updates by Seini Moimoi | Jan 8, 2025 | Portfolio News
Boston Scientific Announces Agreement to Acquire Bolt Medical, Inc. by Seini Moimoi | Jan 8, 2025 | Portfolio News
